MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 28, 2005; DOI: 10.1124/mol.105.018275


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.018275v1
69/2/608    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by crossthwaite, a. j
Right arrow Articles by Cooper, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by crossthwaite, a. j
Right arrow Articles by Cooper, D. M.


Received for publication August 18, 2005.
Revised October 28, 2005.
Accepted for publication October 28, 2005.

A direct interaction between the N-terminus of adenylyl cyclase AC 8 and the catalytic subunit of protein phosphatase 2A

andrew j crossthwaite 1, antonio ciruela 1, timothy f rayner 1, Dermot MF Cooper 2*

1 university of cambridge 2 University of Cambridge

* Address correspondence to: E-mail: dmfc2{at}cam.ac.uk

Abstract

Although protein scaffolding complexes compartmentalize protein kinase A (PKA) and phosphodiesterases to optimize cAMP signalling, adenylyl cyclases, the sources of cAMP, have been implicated in very few direct protein interactions. The N-termini of adenylyl cyclases are highly divergent, which hints at isoform-specific interactions. Indeed, the Ca2+-sensitive adenylyl cyclase 8 (AC8) contains a Ca2+/calmodulin binding site on the N-terminus that is essential for stimulation of activity by the capacitative entry of Ca2+ in the intact cell. Here, we have used the N-terminus of AC8 as a bait in a yeast 2-hybrid screen of a HEK 293 cell cDNA library, and identified the catalytic subunit of the serine/threonine protein phosphatase 2A (PP2AC) as a binding partner. Confirming the highly specific nature of this novel interaction, GST fusion proteins containing the full length N-terminus of AC8 affinity-precipitated catalytically active PP2AC from both HEK293 and mouse forebrain membranes -- the latter a normal source of AC8. The scaffolding subunit of PP2A (PP2AA; 65kDa) was also precipitated by the N-terminus of AC8, indicating that AC8 may occur in a complex with the PP2A core dimer. Intriguingly, the interaction between the N-terminus of AC8 and PP2AC was antagonized by Ca2+/calmodulin. However, PP2AC and Ca2+/calmodulin did not share identical binding specificities in the N-terminus of AC8. PKA-mediated phosphorylation did not influence either calmodulin or PP2AC association with AC8. In addition, both PP2AC and AC8 occurred in lipid rafts. These findings are the first demonstration of an association between adenylyl cyclase and any downstream element of cAMP signaling.


Key words: Adenylyl cyclases, cAMP, Calcium (G Protein Coupled Signals), Protein ser/thr Phosphatases


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. S. Murthy and W. Sriwai
Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A
Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G327 - G335.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev, July 1, 2007; 87(3): 965 - 1010.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics